Provided by Tiger Trade Technology Pte. Ltd.

Celldex Therapeutics

31.65
-0.5300-1.65%
Post-market: 32.000.3500+1.11%19:38 EDT
Volume:2.41M
Turnover:76.17M
Market Cap:2.48B
PE:-7.29
High:32.54
Open:32.26
Low:30.98
Close:32.18
52wk High:45.14
52wk Low:22.10
Shares:78.49M
Float Shares:73.02M
Volume Ratio:1.22
T/O Rate:3.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.3401
EPS(LYR):-3.9000
ROE:-43.88%
ROA:-27.62%
PB:3.48
PE(LYR):-8.12

Loading ...

Celldex Announces Positive Results from Phase 3 Embarq-Csu1 and Embarq-Csu2 Studies of Barzolvolimab Which Met Primary and All Key Secondary Endpoints

THOMSON REUTERS
·
Sep 22

Celldex Therapeutics, - Barzolvolimab Well-Tolerated with Favorable Safety Profile Through 24 Weeks

THOMSON REUTERS
·
Sep 22

Celldex Therapeutics, - Phase 3 Trials Met Primary and All Key Secondary Endpoints at Week 12

THOMSON REUTERS
·
Sep 22

Celldex Therapeutics, - Treatment to Continue to 52 Weeks; Bla Submission Planned for 2027

THOMSON REUTERS
·
Sep 22

Celldex Announces Positive Results from Phase 3 EMBARQ-CSU1 and EMBARQ-CSU2 Studies of Barzolvolimab Which Met Primary and All Key Secondary Endpoints

GlobeNewswire
·
Sep 22

Barzolvolimab’s Strong CSU Prospects Lead Sam Slutsky to Reaffirm Buy on CLDX with Unchanged $56 Price Target

TIPRANKS
·
Sep 21

Analysts Are Bullish on These Healthcare Stocks: Immunic (IMUX), Celldex (CLDX)

TIPRANKS
·
Sep 10

Celldex Therapeutics Inc : Morgan Stanley Raises Target Price to $50.00 from $46.00

THOMSON REUTERS
·
Sep 10

U.S. Research Roundup-Caseys General Stores, Targa Resources, United Rentals

Reuters
·
Sep 10

Celldex Management to Join Cantor Global Healthcare Conference Fireside Chat

Reuters
·
Sep 09

Celldex Posts Investor Presentation Highlighting Barzolvolimab Late-Stage Chronic Urticaria Program Milestones

Reuters
·
Aug 15

Celldex Therapeutics (CLDX) Reported Wider Losses, Is It Still Undervalued?

Simply Wall St.
·
Aug 12

Celldex (CLDX) Gets a Buy from Jefferies

TIPRANKS
·
Aug 08

Celldex Therapeutics is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Aug 08

Analysts Offer Insights on Healthcare Companies: Zoetis (ZTS) and Celldex (CLDX)

TIPRANKS
·
Aug 08

Celldex price target raised to $46 from $40 at Morgan Stanley

TIPRANKS
·
Aug 07

Celldex Therapeutics Q2 EPS $(0.94) Beats $(1.07) Estimate, Sales $22.000K Miss $954.444K Estimate

Benzinga Earnings
·
Aug 07

Celldex Therapeutics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 07

Celldex Q2 FY26 Net Loss Widens to $73.5 Million; R&D Expenses Climb to $67.5 Million

Reuters
·
Aug 07

Celldex Therapeutics Q2 Revenue USD 22 Thousand

THOMSON REUTERS
·
Aug 07